Literature DB >> 18251756

Clinical pharmacology--providing tools and expertise for translational medicine.

J K Aronson, A Cohen, L D Lewis.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18251756      PMCID： PMC2291234          DOI： 10.1111/j.1365-2125.2008.03101.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  20 in total

1.  Individualizing drug therapy, and 'men behaving badly'.

Authors:  E J Begg
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 2.  The role of pharmacogenetics in cancer therapeutics.

Authors:  Wei Peng Yong; Federico Innocenti; Mark J Ratain
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

3.  Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.

Authors:  N K Zgheib; R F Frye; T S Tracy; M Romkes; R A Branch
Journal:  Br J Clin Pharmacol       Date:  2006-10-19       Impact factor: 4.335

4.  Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.

Authors:  Kong M Li; Laurent P Rivory; Janelle Hoskins; Rohini Sharma; Stephen J Clarke
Journal:  Br J Clin Pharmacol       Date:  2006-07-07       Impact factor: 4.335

5.  The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example.

Authors:  Gemma L Dickinson; Martin S Lennard; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2007-02-12       Impact factor: 4.335

6.  Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging.

Authors:  B J Van der Schueren; J N de Hoon; F H Vanmolkot; A Van Hecken; M Depre; S A Kane; I De Lepeleire; S R Sinclair
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

7.  Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.

Authors:  Martijn van Doorn; Jack Vogels; Albert Tas; Ewoud Jan van Hoogdalem; Jacobus Burggraaf; Adam Cohen; Jan van der Greef
Journal:  Br J Clin Pharmacol       Date:  2007-05       Impact factor: 4.335

8.  Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes.

Authors:  Vincent C Peterkin; Jonathan N Bauman; Theunis C Goosen; Lee Menning; Michael Z Man; Joseph D Paulauskis; J Andrew Williams; Scott P Myrand
Journal:  Br J Clin Pharmacol       Date:  2007-06-06       Impact factor: 4.335

9.  Add-on therapy with doxazosin in patients with hypertension influences arterial stiffness and albuterol-mediated arterial vasodilation.

Authors:  Andrzej Wykretowicz; Przemyslaw Guzik; Tomasz Krauze; Karolina Adamska; Agata Milewska; Henryk Wysocki
Journal:  Br J Clin Pharmacol       Date:  2007-07-17       Impact factor: 4.335

10.  Translational Medicine: A two-way road.

Authors:  Francesco M Marincola
Journal:  J Transl Med       Date:  2003-07-24       Impact factor: 5.531
View more
  10 in total

1.  Novel targets and regulatory ordeal by QT interval.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

2.  Clinical pharmacology and therapeutics in the UK--a great instauration.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2010-02       Impact factor: 4.335

3.  How to attract, retain and nurture young academic clinicians.

Authors:  Jeffrey K Aronson
Journal:  J R Soc Med       Date:  2011-01       Impact factor: 5.344

4.  Looking back: editors' pick of 2008.

Authors:  Y K Loke; A Somogyi; L D Lewis; M Schachter; A F Cohen; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

5.  1974-2014: Reflections on the evolution of clinical pharmacology in the past 40 years and a message to our readers.

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

6.  Methods in clinical pharmacology.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

7.  Prediction and reverse prediction in therapeutics and toxicology.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2008-10       Impact factor: 4.335

8.  Endothelial progenitor cells & translational research.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

9.  What do clinical pharmacologists do? A questionnaire survey of senior UK clinical pharmacologists.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

10.  Medication errors: EMERGing solutions.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2009-06       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.